CORIS BIOCONCEPT

medical devices

About

Coris BioConcept is a Belgium-based company founded in 1996, specializing in the development, manufacturing, and marketing of rapid in vitro diagnostic tests for human infectious diseases. Headquartered in Gembloux, Wallonia, the company employs around 28 people and generates an annual revenue of approximately $5.6 million. Coris BioConcept is certified with ISO 13485, and all products meet CE marking requirements, ensuring high quality and regulatory compliance. The company offers a wide range of rapid diagnostic kits that target infectious diseases caused by bacteria, viruses, and parasites. Their product portfolio includes tests for respiratory, gastroenteric, and blood-borne pathogens, as well as specialized assays for detecting antibiotic resistance mechanisms. Coris BioConcept also focuses on research and development to create innovative solutions that address emerging health challenges, particularly in antimicrobial resistance. Their products are utilized by microbiology laboratories and healthcare professionals in over 60 countries worldwide.

Technologies

MailJet Outlook MailChimp SPF Microsoft Office 365 Google Tag Manager Google Font API Mobile Friendly MailChimp YouTube Google Analytics reCAPTCHA Bootstrap Framework

Keywords

in vitro diagnostic real time pcr molecular biology lateral flow amr immunochromatography antibiotic resistance carbapenemases rapid tests rt-lamp assays bacterial detection tests k-set lateral flow resist range hat sero lateral flow antigen detection crypto/giardia duo-strip ce marked diagnostics bacterial diagnostics respiratory syncytial virus test pathogen detection parasitic infection tests medical microbiology medical devices influenza a+b lateral flow electrochemical detection coris bioconcept medical equipment and supplies manufacturing rapid diagnostic tests diagnostics multiplex assays

Location

11 Rue Guillaume Fouquet, Gembloux, Walloon Region, Belgium, 5032

Related Companies

Companies in the same industry